Ever Source Wealth Advisors, LLC Myriad Genetics Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 357 shares of MYGN stock, worth $3,573. This represents 0.0% of its overall portfolio holdings.
Number of Shares
357
Previous 481
25.78%
Holding current value
$3,573
Previous $13,000
69.23%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MYGN
# of Institutions
228Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$152 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$55.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$43.5 Million0.03% of portfolio
-
Glenview Capital Management, LLC New York, NY4.16MShares$41.6 Million1.44% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $807M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...